Does RUXOLITINIB Cause Splenic infarction? 72 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 72 reports of Splenic infarction have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.1% of all adverse event reports for RUXOLITINIB.
72
Reports of Splenic infarction with RUXOLITINIB
0.1%
of all RUXOLITINIB reports
17
Deaths
45
Hospitalizations
How Dangerous Is Splenic infarction From RUXOLITINIB?
Of the 72 reports, 17 (23.6%) resulted in death, 45 (62.5%) required hospitalization, and 11 (15.3%) were considered life-threatening.
Is Splenic infarction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 72 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Splenic infarction?
CISPLATIN (37)
HEPARIN (37)
ASPIRIN (35)
APIXABAN (33)
RIVAROXABAN (31)
PREDNISONE (28)
VENETOCLAX (28)
LENALIDOMIDE (26)
BEVACIZUMAB (25)
METFORMIN (25)
Which RUXOLITINIB Alternatives Have Lower Splenic infarction Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE